In a case of stillbirth at 28 weeks gestation with no fetal heartbeat, what is the best specimen for chromosomal analysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Specimen for Chromosomal Analysis in Stillbirth

Amniotic fluid is the best specimen for chromosomal analysis in stillbirth cases, offering the highest success rate for karyotyping (83%) and reliable cell culture even after fetal demise. 1

Why Amniotic Fluid is Superior

Amniotic fluid contains viable fetal cells shed from multiple fetal tissues (skin, bladder, gastrointestinal tract, and amnion), making it an excellent source for chromosomal analysis even after fetal death. 1 This is critical because the primary challenge in stillbirth cytogenetic analysis is obtaining viable cells from a deceased fetus.

Success Rates by Specimen Type

The evidence clearly demonstrates marked differences in diagnostic success:

  • Amniotic fluid: 83% success rate for karyotyping 2
  • Placental tissue: 78% success rate for karyotyping 2
  • Fetal cord blood: 6.3% success rate for karyotyping 2
  • Umbilical cord sampling: Not recommended due to extremely low yield 2

Fetal blood from the umbilical cord has the lowest success rate (6.3%) among all tissue types for chromosomal analysis in stillbirth. 2 This is because blood cells undergo rapid autolysis after fetal death, making cell culture nearly impossible. 3

Critical Timing Consideration

Amniocentesis should be performed at the time of stillbirth diagnosis rather than waiting for delivery, as postmortem tissue changes rapidly make it impossible to successfully culture fetal cells. 3 This recommendation comes from a study where amniocentesis at diagnosis achieved 100% success in obtaining cytogenetic results, while fetal tissue culture after delivery succeeded in only 25% of cases. 3

Why NOT Umbilical Cord or Fetal Cord Blood

Umbilical cord blood reflects rapid cellular degradation after fetal demise, with only 6.3% successful karyotyping compared to 83% with amniotic fluid. 2 The cells in fetal blood undergo autolysis much faster than amniotic fluid cells, which remain viable longer due to the protective environment of the amniotic cavity. 3

Placental tissue should be avoided as the primary specimen due to confined placental mosaicism, which may show chromosomal abnormalities not present in the fetus or vice versa. 1

Modern Testing Approach

While the question asks about traditional karyotyping specimens, it's worth noting that chromosomal microarray analysis (CMA) achieves 100% success rate regardless of tissue type and detects submicroscopic abnormalities missed by karyotyping. 2, 4 However, when CMA is not available or for traditional karyotyping, amniotic fluid remains the gold standard specimen. 1

Common Pitfalls to Avoid

  • Never wait until delivery to collect specimens - tissue maceration and autolysis increase exponentially with time after fetal death 3
  • Do not rely on umbilical cord blood - it has the worst success rate of all specimen types 2
  • Avoid using only placental tissue - confined placental mosaicism limits diagnostic accuracy 1
  • Document time of collection after death - laboratories need this information for specimen acceptance 1

Answer to the Question

B - Amniotic fluid is the correct answer, with an 83% success rate for chromosomal analysis in stillbirth cases, compared to only 6.3% for fetal cord blood. 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.